163 related articles for article (PubMed ID: 23103096)
1. Facile synthesis and anticancer activity of C-10 non-acetal deoxoartemisinin dimers.
Phothongkam S; Chancharunee S; Saovapakhiran A; Wichai U; Pohmakotr M
Bioorg Med Chem Lett; 2012 Dec; 22(24):7598-601. PubMed ID: 23103096
[TBL] [Abstract][Full Text] [Related]
2. Antimalarial and antitumor evaluation of novel C-10 non-acetal dimers of 10beta-(2-hydroxyethyl)deoxoartemisinin.
Jeyadevan JP; Bray PG; Chadwick J; Mercer AE; Byrne A; Ward SA; Park BK; Williams DP; Cosstick R; Davies J; Higson AP; Irving E; Posner GH; O'Neill PM
J Med Chem; 2004 Feb; 47(5):1290-8. PubMed ID: 14971909
[TBL] [Abstract][Full Text] [Related]
3. Antitumor activity of novel deoxoartemisinin monomers, dimers, and trimer.
Jung M; Lee S; Ham J; Lee K; Kim H; Kim SK
J Med Chem; 2003 Mar; 46(6):987-94. PubMed ID: 12620075
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and anticancer activity of novel amide derivatives of non-acetal deoxoartemisinin.
Jung M; Park N; Moon HI; Lee Y; Chung WY; Park KK
Bioorg Med Chem Lett; 2009 Nov; 19(22):6303-6. PubMed ID: 19819696
[TBL] [Abstract][Full Text] [Related]
5. Antiprotozoal, anticancer and antimicrobial activities of dihydroartemisinin acetal dimers and monomers.
Slade D; Galal AM; Gul W; Radwan MM; Ahmed SA; Khan SI; Tekwani BL; Jacob MR; Ross SA; Elsohly MA
Bioorg Med Chem; 2009 Dec; 17(23):7949-57. PubMed ID: 19879765
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of dihydroartemisinin and dihydroartemisitene acetal dimers showing anticancer and antiprotozoal activity.
Galal AM; Gul W; Slade D; Ross SA; Feng S; Hollingshead MG; Alley MC; Kaur G; ElSohly MA
Bioorg Med Chem; 2009 Jan; 17(2):741-51. PubMed ID: 19084416
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of a novel series of artemisinin dimers with potent anticancer activity involving Sonogashira cross-coupling reaction.
Buragohain P; Saikia B; Surineni N; Barua NC; Saxena AK; Suri N
Bioorg Med Chem Lett; 2014 Jan; 24(1):237-9. PubMed ID: 24332623
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and anticancer activity of novel deoxoartemisinin-glycolipid hybrids.
Min D; Kim M; Ricci J; Jung S; Kim K; Chung WY; Park KK; Jung M
Chem Pharm Bull (Tokyo); 2014; 62(5):446-53. PubMed ID: 24614158
[TBL] [Abstract][Full Text] [Related]
9. Antiangiogenic activity of deoxoartemisinin derivatives on chorioallantoic membrane.
Jung M; Tak J; Chung WY; Park KK
Bioorg Med Chem Lett; 2006 Mar; 16(5):1227-30. PubMed ID: 16380253
[TBL] [Abstract][Full Text] [Related]
10. New artesunic acid homodimers: potent reversal agents of multidrug resistance in leukemia cells.
Reiter C; Herrmann A; Çapci A; Efferth T; Tsogoeva SB
Bioorg Med Chem; 2012 Sep; 20(18):5637-41. PubMed ID: 22884578
[TBL] [Abstract][Full Text] [Related]
11. Biological mechanisms of action of novel C-10 non-acetal trioxane dimers in prostate cancer cell lines.
Alagbala AA; McRiner AJ; Borstnik K; Labonte T; Chang W; D'Angelo JG; Posner GH; Foster BA
J Med Chem; 2006 Dec; 49(26):7836-42. PubMed ID: 17181166
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of novel ring-contracted artemisinin dimers with potent anticancer activities.
Zhang N; Yu Z; Yang X; Hu P; He Y
Eur J Med Chem; 2018 Apr; 150():829-840. PubMed ID: 29597166
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of extraordinarily potent C-10 carba artemisinin dimers against P. falciparum malaria parasites and HL-60 cancer cells.
Chadwick J; Mercer AE; Park BK; Cosstick R; O'Neill PM
Bioorg Med Chem; 2009 Feb; 17(3):1325-38. PubMed ID: 19136263
[TBL] [Abstract][Full Text] [Related]
14. Stereoselective Access to Antimelanoma Agents by Hybridization and Dimerization of Dihydroartemisinin and Artesunic acid.
Botta L; Cesarini S; Zippilli C; Filippi S; Bizzarri BM; Baratto MC; Pogni R; Saladino R
ChemMedChem; 2021 Jul; 16(14):2270-2277. PubMed ID: 33792170
[TBL] [Abstract][Full Text] [Related]
15. Anticancer and antimalarial efficacy and safety of artemisinin-derived trioxane dimers in rodents.
Posner GH; McRiner AJ; Paik IH; Sur S; Borstnik K; Xie S; Shapiro TA; Alagbala A; Foster B
J Med Chem; 2004 Feb; 47(5):1299-301. PubMed ID: 14971910
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of novel S-linked dihydroartemisinin derivatives and evaluation of their anticancer activity.
Gour R; Ahmad F; Prajapati SK; Giri SK; Lal Karna SK; Kartha KPR; Pokharel YR
Eur J Med Chem; 2019 Sep; 178():552-570. PubMed ID: 31216504
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of indolyl chalcones as antitumor agents.
Kumar D; Kumar NM; Akamatsu K; Kusaka E; Harada H; Ito T
Bioorg Med Chem Lett; 2010 Jul; 20(13):3916-9. PubMed ID: 20627724
[TBL] [Abstract][Full Text] [Related]
18. Orally active, antimalarial, anticancer, artemisinin-derived trioxane dimers with high stability and efficacy.
Posner GH; Paik IH; Sur S; McRiner AJ; Borstnik K; Xie S; Shapiro TA
J Med Chem; 2003 Mar; 46(6):1060-5. PubMed ID: 12620083
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and preliminary bioevaluation of novel E-ring modified acetal analog of camptothecin as cytotoxic agents.
Zhu L; Zhuang C; Lei N; Guo Z; Sheng C; Dong G; Wang S; Zhang Y; Yao J; Miao Z; Zhang W
Eur J Med Chem; 2012 Oct; 56():1-9. PubMed ID: 23084702
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of novel artemisinin derivatives with potent activities against colorectal cancer in vitro and in vivo.
Wang LL; Kong L; Liu H; Zhang Y; Zhang L; Liu X; Yuan F; Li Y; Zuo Z
Eur J Med Chem; 2019 Nov; 182():111665. PubMed ID: 31494469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
